Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

Erratum to: OsteoporosisDOI 10.1007/s00198-008-0712-1

Tables 7, 8, 9, 10 and Figs. 2, 3, 4 of this article, inadvertently printed in black and white, were intended to be printed in colour. In addition there was an error in the scale of the y-axis of Fig. 4. The relevant tables and figures are reproduced below.

Fig. 2

Relation between the 10-year probability of a major osteoporotic fracture and the 10-year probability of a hip fracture in women aged 50 years from the UK. Each point represents a particular combination of BMD and clinical risk factors

Fig. 3

Correlation between the probability of fracture and cost effectiveness at the age of 50 years in women (BMI set to 26 kg/m²). The upper panel shows the 10-year probability of hip fracture and the lower panel the probability of a major osteoporotic fracture. Each point represents a particular combination of BMD and clinical risk factors

Fig. 4

Management chart for osteoporosis. The brown area in the left hand panel shows the limits of fracture probabilities for the assessment of BMD. The right hand panel gives the intervention threshold

Table 7 Management decisions (N, no action; B, BMD testing at the femoral neck; T, treatment without BMD) in women according to risk factors and age (BMI=23.9)

Table 8 Management decisions (N, no action; B, BMD testing at the femoral neck; T, treatment without BMD) in women according to risk factors and age (BMI=23.9)

Table 9 Assessment chart for men and women with clinical risk factors (CRFs) for fracture without information on BMD

Table 10 Assessment chart for men and women with clinical risk factors (CRFs) for fracture